MedTrace Logo

Stool and Serum CMV-PCR in Diagnosing CMV Colitis

NCT05522283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2022-09-01

No results posted yet for this study

Summary

CMV viral load detected by real-time polymerase chain reaction (PCR) in either serum or stool may be beneficial in diagnosing CMV colitis, but the data is limited. Therefore, we aimed to investigate the diagnostic performance of stool CMV-PCR, serum CMV-PCR, and their combination in diagnosing CMV colitis using tissue histopathology as the standard reference in patients with clinical suspicion of CMV colitis.

Conditions

  • CMV Colitis

Interventions

DIAGNOSTIC_TEST

Stool and blood CMV PCR

Quantitative stool CMV-PCR (CMV R-gene® kit, limit of detection 450 copies/ml, Biomerieux, France) and quantitative serum CMV-PCR (Cobas® CMV, limit of detection 150 copies/ml, Roche, USA) were collected within seven days of colonoscopy.

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05522283 on ClinicalTrials.gov